{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:28:28Z","timestamp":1791300508297,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1997,7,1]],"date-time":"1997-07-01T00:00:00Z","timestamp":867715200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[1997,7]]},"DOI":"10.1038\/ng0797-270","type":"journal-article","created":{"date-parts":[[2004,8,18]],"date-time":"2004-08-18T20:32:02Z","timestamp":1092861122000},"page":"270-276","source":"Crossref","is-referenced-by-count":490,"title":["Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors"],"prefix":"10.1038","volume":"16","author":[{"given":"Richard O.","family":"Snyder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol H.","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gijsbert A.","family":"Patijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Kaye","family":"Spratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Danos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dea","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen M.","family":"Gown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Winther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Meuse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence K.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur R","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Kay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFng0797270_CR1","first-page":"3181","volume-title":"The Metabolic Basis oJ Inherited Disease Vol. 3","author":"AP Reiner","year":"1995","unstructured":"Reiner, A.P. & Davie, E.W. Introduction to hemostasis and the vitamin K-dependent coagulation factors. in The Metabolic Basis oJ Inherited Disease Vol. 3 (eds Scriver, C.R., Beaudet, A.L, Sly, W.S. & Valle, D.) 3181\u20133221 (McGraw-Hill, New York, 1995)."},{"key":"BFng0797270_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1126\/science.8211118","volume":"262","author":"MA Kay","year":"1993","unstructured":"Kay, M.A. et al. In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-deficient dogs. Science 262, 117\u2013119 (1993).","journal-title":"Science"},{"key":"BFng0797270_CR3","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1073\/pnas.91.6.2353","volume":"91","author":"MA Kay","year":"1994","unstructured":"Kay, M.A. et al. In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs. Proc. Natl. Acad. Sci. USA 91, 2353\u20132357 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng0797270_CR4","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.1073\/pnas.91.10.4407","volume":"91","author":"Y Yang","year":"1994","unstructured":"Yang, Y. et al. Cellular immunity to viral antigelns limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91, 4407\u20134411 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng0797270_CR5","first-page":"97","volume":"158","author":"N Muzyczka","year":"1992","unstructured":"Muzyczka, N. Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr. Top. Microbiol. Immunol. 158, 97\u2013129 (1992).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"BFng0797270_CR6","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.1128\/JVI.70.11.8098-8108.1996","volume":"70","author":"X Xiao","year":"1996","unstructured":"Xiao, X., Li, J. & Samulski, R.J. Efficient long-term gene transfer into muscle of immunocompetent mice by an adeno-associatfed virus vector. J. Virol. 70, 8098\u20138108 (1996).","journal-title":"J. Virol."},{"key":"BFng0797270_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0006-8993(95)01488-8","volume":"713","author":"TJ McCown","year":"1996","unstructured":"McCown, T.J., Xiao, X., Li, J., Breese, G.R. & Samulski, R.J. Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res. 713, 99\u2013107 (1996).","journal-title":"Brain Res."},{"key":"BFng0797270_CR8","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1016\/S0003-4975(96)00946-0","volume":"62","author":"MG Kaplitt","year":"1996","unstructured":"Kaplitt, M.G. et al. Long-term gene transfer into porcine myocadium following selective percutaneous coronary artery infusion of an adeno-associated virus vector. Ann. Thorac. Surg. 62, 1669\u20131676 (1996).","journal-title":"Ann. Thorac. Surg."},{"key":"BFng0797270_CR9","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/ng1094-148","volume":"8","author":"MG Kaplitt","year":"1994","unstructured":"Kaplitt, M.G. et al. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nature Genet. 8, 148\u2013154 (1994).","journal-title":"Nature Genet."},{"key":"BFng0797270_CR10","first-page":"588","volume":"3","author":"AK Lalwani","year":"1996","unstructured":"Lalwani, A.K., Walsh, B.J., Reilly, P.G., Muzyczka, N. & Mhatre, A.N. Development of in vivo gene therapy for hearing disorders: Introduction of adeno-associated virus into the cochlea of guinea pig. Gene Ther. 3, 588\u2013592 (1996).","journal-title":"Gene Ther."},{"key":"BFng0797270_CR11","doi-asserted-by":"publisher","first-page":"10613","DOI":"10.1073\/pnas.90.22.10613","volume":"90","author":"TR Flotte","year":"1993","unstructured":"Flotte, T.R. et al. Stable in vivo expression Of the cystic fibrosis transmembrane conductance regulator with an adeno-associaked virus vector. Proc Natl. Acad. Sci. USA. 90, 10613\u201310617 (1993).","journal-title":"Proc Natl. Acad. Sci. USA."},{"key":"BFng0797270_CR12","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1128\/JVI.70.5.3235-3241.1996","volume":"70","author":"SA Afione","year":"1996","unstructured":"Afione, S.A. et al. In vivo model of adeno-associated virus vector persistence and rescue. J. Virol. 70, 3235\u20133241 (1996).","journal-title":"J. Virol."},{"key":"BFng0797270_CR13","first-page":"155","volume-title":"Handbook of Parvoviruses. Vol. 1","author":"BJ Carter","year":"1990","unstructured":"Carter, B.J. The growth cycle of adeno-associattd virus. in Handbook of Parvoviruses. Vol. 1 (ed. Tijssen, P.) 155\u2013168 (CRC Press, Boca Raton, FL, 1990)."},{"key":"BFng0797270_CR14","first-page":"151","volume":"2","author":"D Barr","year":"1995","unstructured":"Barr, D. et al. Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther. 2, 151\u2013155 (1995).","journal-title":"Gene Ther."},{"key":"BFng0797270_CR15","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1128\/JVI.70.1.520-532.1996","volume":"70","author":"KJ Fisher","year":"1996","unstructured":"Fisher, K.J.. et al. Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J. Virol. 70, 520\u2013532 (1996).","journal-title":"J. Virol."},{"key":"BFng0797270_CR16","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1073\/pnas.90.8.3539","volume":"90","author":"G Dranoff","year":"1993","unstructured":"Dranoff, G. et al. Vaccination with irridateq tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulate potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA 90, 3539\u20133543 (1993).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng0797270_CR17","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1089\/hum.1992.3.6-641","volume":"3","author":"MA Kay","year":"1992","unstructured":"Kay, M.A. et al. Hepatic gene therapy: persistertt expression of human arantitrypsin in mice after direct gene deliveryin vivo. Hum. Gene Ther. 3, 641\u2013647 (1992).","journal-title":"Hum. Gene Ther."},{"key":"BFng0797270_CR18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1073\/pnas.89.1.89","volume":"89","author":"MA Kay","year":"1992","unstructured":"Kay, M.A. et al. Expression of human \u03b11-antitrypsin in dogs after autologous transplantation of retroviral transduced hepapcytes. Proc Natl. Acad. Sci. USA. 89, 89\u201393 (1992).","journal-title":"Proc Natl. Acad. Sci. USA."},{"key":"BFng0797270_CR19","first-page":"802","volume":"3","author":"ZS Guo","year":"1996","unstructured":"Guo, Z.S., Wang, L.H., Eisensmith, R.C. & Woo, S.L.C. Evaluation of promoter strength for hepatic gene expression in vivo following adenovirus-mediated gene transfer. Gene Ther. 3, 802\u2013810 (1996).","journal-title":"Gene Ther."},{"key":"BFng0797270_CR20","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1128\/JVI.70.5.3207-3214.1996","volume":"70","author":"JF Baskar","year":"1996","unstructured":"Baskar, J.F. et al. The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific -specific expression in transgenic mice. J. Virol. 70, 3207\u20133214 (1996).","journal-title":"J. Virol."},{"key":"BFng0797270_CR21","first-page":"269","volume":"107","author":"GL Bray","year":"1986","unstructured":"Bray, G.L., Weinmann, A.F. & Thompson, A.R. Calcium-specific immunoassays for fator IX: reduced levels of antigen in patients with vitamin K disorders. J. Lab. Clin. Med. 107, 269\u2013278 (1986).","journal-title":"J. Lab. Clin. Med."},{"key":"BFng0797270_CR22","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1128\/JVI.70.5.3227-3234.1996","volume":"70","author":"FK Ferrari","year":"1996","unstructured":"Ferrari, F.K., Samulski, T., Shenk, T. & Samulski, R.J. Second-strand synthesis is a rate limiting step for efficient transduction by recombinant adeno-associated virus vectors. J. Virol. 70, 3227\u20133234 (1996).","journal-title":"J. Virol."},{"key":"BFng0797270_CR23","doi-asserted-by":"crossref","first-page":"8282","DOI":"10.1128\/JVI.68.12.8282-8287.1994","volume":"68","author":"IE Alexander","year":"1994","unstructured":"Alexander, I.E., Russell, D.W. & Miller, A.D. DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vectors. J. Virol. 68, 8282\u20138287 (1994).","journal-title":"J. Virol."},{"key":"BFng0797270_CR24","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1128\/JVI.62.6.1963-1973.1988","volume":"62","author":"SK McLaughlin","year":"1988","unstructured":"McLaughlin, S.K., Collis, P., Hermonat, P.L. & Muzyczka, N. Adeno-associated virus general transduction vectors: analysis of proviral structures. J. Virol. 62, 1963\u20131973 (1988).","journal-title":"J. Virol."},{"key":"BFng0797270_CR25","doi-asserted-by":"publisher","first-page":"14082","DOI":"10.1073\/pnas.93.24.14082","volume":"93","author":"PD Kessler","year":"1996","unstructured":"Kessler, P.D. et al. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc. Natl. Acad. Sci. USA 93, 14082\u201314087 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng0797270_CR26","doi-asserted-by":"publisher","first-page":"278","DOI":"10.2144\/96202rr05","volume":"20","author":"MTFD Vrancken Peeters","year":"1996","unstructured":"Vrancken Peeters, M.T.F.D., Lieber, A., Perkins, J. & Kay, M.A. Method for multiple portal vein infusions in mice: Quantitation of adenovirus-mediated hepatic gene transfer. Biotechniques 20, 278\u2013285 (1996).","journal-title":"Biotechniques"},{"key":"BFng0797270_CR27","doi-asserted-by":"crossref","first-page":"8944","DOI":"10.1128\/JVI.70.12.8944-8960.1996","volume":"70","author":"A Lieber","year":"1996","unstructured":"Lieber, A., He, C.-Y., Kirllova, I. & Kay, M.A. Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo. J. Virol. 70, 8944\u20138960 (1996).","journal-title":"J. Virol."},{"key":"BFng0797270_CR28","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0168-9525(94)90173-2","volume":"10","author":"MA Kay","year":"1994","unstructured":"Kay, M.A. & Woo, S.L.C. Gene therapy for metabolic disorders. Trends Genet. 10, 253\u2013257 (1994).","journal-title":"Trends Genet."},{"key":"BFng0797270_CR29","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1089\/hum.1996.7.4-463","volume":"7","author":"H Su","year":"1996","unstructured":"Su, H., Chang, J.C., Xu, S.M. & Kan, Y.W. Selective killing of AFP-positive hepatocellular carcinoma cells by adeno-associated virus transfer of the herpes simplex virus thymidine kinase gene. Hum. Gene Ther. 7, 463\u2013470 (1996).","journal-title":"Hum. Gene Ther."},{"key":"BFng0797270_CR30","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1073\/pnas.85.9.3150","volume":"85","author":"D Louis St.","year":"1988","unstructured":"St. Louis, D. & Verma, I.M. An alternative approach to somatic cell gene therapy. Proc. Natl. Acad. Sci. USA 85, 3150\u20133154 (1988).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng0797270_CR31","first-page":"1","volume-title":"Current Protocols in Human Genetics Vol. 1","author":"RO Snyder","year":"1996","unstructured":"Snyder, R.O., Xiao, X. Production of recombinant adeno-associated viral vectors. in Current Protocols in Human Genetics Vol. 1 (eds Dracopoli, N. et al.) 1\u201324 (John Wiley & Sons, New York, 1996)."},{"key":"BFng0797270_CR32","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1099\/0022-1317-36-1-59","volume":"36","author":"FL Graham","year":"1977","unstructured":"Graham, F.L., Smiley, J., Russell, W.C. & Nairn, R. Characterization of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36, 59\u201374 (1977).","journal-title":"J. Gen. Virol."},{"key":"BFng0797270_CR33","unstructured":"Li, J., Samulski, R.J. & Xiao, X. Role for highly regulated rep gene expression in adeno-associated virus vector production. J. Virol. (in the press)."},{"key":"BFng0797270_CR34","first-page":"922","volume":"88","author":"AR Thompson","year":"1976","unstructured":"Thompson, A.R. & Counts, R.B. Removal of heparin and protamine from plasma. J. Lab. Clin. Med. 88, 922\u2013929 (1976).","journal-title":"J. Lab. Clin. Med."},{"key":"BFng0797270_CR35","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1182\/blood.V62.5.1027.1027","volume":"62","author":"AR Thompson","year":"1983","unstructured":"Thompson, A.R. Monoclonal antibody to an epitope on the heavy chain of factor IX missing in three hemophilia B patients. Blood 62, 1027\u20131034 (1983).","journal-title":"Blood"},{"key":"BFng0797270_CR36","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/sj.gt.3300398","volume":"4","author":"DB Schowalter","year":"1997","unstructured":"Schowalter, D.B., Tubb, J.C., Liu, M., Wilson, C.B. & Kay, M.A. Heterologous expression of adenovirus E3-gp19K in an E1a deleted adenovirus vector inhibits MHCI expression in vitro but does not prolong transgene expression in vivo. Gene Ther. 4, 351\u2013360 (1997).","journal-title":"Gene Ther."}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ng0797-270","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng0797-270.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng0797-270.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:49:08Z","timestamp":1684442948000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ng0797-270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,7]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1997,7]]}},"alternative-id":["BFng0797270"],"URL":"https:\/\/doi.org\/10.1038\/ng0797-270","relation":{},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,7]]}}}